Wu, Qian http://orcid.org/0000-0002-5413-8924
Sun, Ming-Shuai http://orcid.org/0000-0003-2645-9568
Liu, Yin-Hua
Ye, Jing-Ming
Xu, Ling http://orcid.org/0000-0002-9236-3014
Funding for this research was provided by:
National Key Research and Development Program of China (2016YFC0901302)
Interdisciplinary Clinical Research Project of Peking University First Hospital (2019CR38)
Article History
Received: 7 June 2023
Accepted: 4 July 2023
First Online: 11 July 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: This study was performed in line with the principles of the Declaration of Helsinki. The ethical approval of this retrospective study was divided into two parts. First, for patients from the Breast Disease Center of Peking University First Hospital, this study was approved by the Ethics Review Committee of Peking University First Hospital (No.2021-283), and informed consent was obtained by telephone during the follow-up. For patients collected from the Breast Cancer Multicenter Clinical Cohort (2016YFC0901302), the study was approved by each participating institution's ethics review committee. Given the retrospective and anonymous nature of the study, additional informed consent specific to this study was not required.